Nutra Pharma, ReceptoPharm Inc. deal

NPHC will acquire the 61.9% of ReceptoPharm it does not already own for 14 million shares. Based on NPHC’s close of $0.17 on June 16, the trading day before the deal was announced, the deal is valued ...